Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2025-12-26 @ 3:21 AM
NCT ID: NCT01405820
Term: Bronchitis
Organ System: Infections and infestations
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 16.1
Notes: None
Study: NCT01405820
Study Brief: Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 0 54 View
EG001 None 0 45 View
EG002 None 0 52 View
EG003 None 0 53 View
EG004 None 0 47 View
EG005 None 0 38 View
EG006 None 0 44 View
EG007 None 1 35 View
EG008 None 0 42 View
EG009 None 0 42 View
EG010 None 0 42 View
EG011 None 0 32 View